Harvard Business Review

APRIL 3, 2017

The CEO of a large Australian company called me to relay a particular strategy development problem his firm was facing, and ask for my advice. P&G made a Where to Play choice to get into the huge, profitable, and growing pharmaceutical business with the acquisition of Norwich Eaton, in 1982. Lafley, called Playing to Win.

First-mover Advantage 15

First-mover Advantage Retail Strategy Pharmaceuticals 15

Harvard Business Review

MARCH 16, 2015

Please note that titles used here reflect the positions the individuals held in 2013, when we conducted the interviews for a separate article ). ” CEOs also worried about whether their high potential employees were being properly developed. As a pharmaceutical company, we obviously were part of that whole ecosystem.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

NOVEMBER 4, 2014

Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary. Even the U.S.

Cost 8

Cost Committee Insurance Health Care 8

Harvard Business Review

NOVEMBER 4, 2014

Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary. Even the U.S.

Cost 8

Cost Committee Insurance Health Care 8

Harvard Business Review

OCTOBER 21, 2013

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. How likely was it that they would be on top of the rapid developments in Asian consumer markets, or in technology and design emanating from Silicon Valley? It’s a tough challenge.

Drucker 8

Drucker Diversity Pharmaceuticals Uncertainty 8

Harvard Business Review

FEBRUARY 14, 2014

Because of Kendall Square’s concentration of talent, and its infrastructure, Novartis, the giant Swiss pharmaceutical company, moved nearly its entire research center here from Switzerland. Not only can natural gas be used as a feedstock for chemicals, fertilizers, pesticides, paints, plastics, and cosmetics, in 2013 the Cummins Corp.

Chemicals 8

Chemicals Pharmaceuticals Energy Creativity 8

Harvard Business Review

JULY 30, 2015

This continues a trend The Association of National Advertisers first reported in 2013. In the “old days,” we might get a standard report of “impressions” from an agency, but today taming that data to make the numbers behave in surprising new ways needs to be developed as an internal core competency. ” 2.

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

SEPTEMBER 22, 2015

As the ire over high prescription drug prices in the United States escalates , it’s easy to blame pharmaceutical companies. But pharmaceutical companies aren’t to blame. rose by 8 times the general inflation rate in 2013. The annual expense for a recently developed cancer drug cocktail is $295,000.

Pharmaceuticals 8

Pharmaceuticals Price Budgeting Insurance 8

Harvard Business Review

FEBRUARY 2, 2015

Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support. Average compensation in 2013 across the advanced industries sector was $90,000—nearly double that of workers in other industries.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

MAY 5, 2016

Within weeks there was $50 billion in business deals involving foreign companies, including the Airbus agreement (worth $25 billion) to sell 118 planes, and Italy’s state rail company’s $5 billion pact to develop the local rail network. However, oil prices have dropped more than 60% since the interim nuclear deal in November 2013.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

AUGUST 17, 2015

When you put all these pieces together around education and health care, it’s clear that Cuba is likely a champion of investment in the development of human capital—but for the last 50 years it has an extremely low economic return on this investment. pharmaceutical company could be a great asset in the future.

Biotechnology 8

Biotechnology Tourism Human Capital Pharmaceuticals 8

Harvard Business Review

MAY 15, 2013

Nor can we develop good approaches to analyzing, preserving and transforming cultures. If we can define what organizational culture is , it gives us a handle on how to diagnose problems and even to design and develop better cultures. Beginning May 1, 2013, I facilitated a discussion around this question on LinkedIn.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

FEBRUARY 11, 2016

Google and Intel rely on experts in social science and biomechanics to develop transformative products by better understanding how people think about and use technology. In 2013, Accenture suggested that 20 to 30 percent of the total workforce falls outside the organization’s traditional full-time, permanent employment relationship.

Agility 8

Agility Organization Resources Fixed Costs 8

Harvard Business Review

NOVEMBER 25, 2015

One 2013 study illustrates this well. Gore & Associates gives people free time and resources to develop new ideas. The Chief Talent Officer at UCB Pharmaceuticals told us how he recently started inviting patients to executive meetings, so the people making decisions can see how their work makes a difference. Insight Center.

Motivation 8

Motivation Company Airlines Learning-by-Doing 8

Harvard Business Review

OCTOBER 27, 2014

doubled from 20% to 40% between July and December 2013, and has stayed at that level since. I studied large-scale change and innovation efforts in 56 randomly selected companies in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries.

Middle Management 14

Middle Management Six Sigma Taylorism Taylor 14

Harvard Business Review

OCTOBER 11, 2013

By 2013, we had honored Jack Dorsey of Twitter, Garrett Camp of Uber, famed choreographer Twyla Tharp, and Gangnam style pop artist Psy. Celine Schillinger sought to change the leadership landscape of Sanofi, a major pharmaceutical company. If you say we should, let’s do it.

Innovation 11

Innovation Christensen Decisionmaking CTO 11

Great Leadership By Dan

FEBRUARY 7, 2014

After motivational ability, the senior executive traits most valued by organizations were: strong ability to manage change (51 percent); ability to identify and develop talent (46 percent); innovative thinking (30 percent); and consistent high performance (26 percent). years), while the pharmaceutical (5.7

Execution 283

Execution Company Press Release Survey 283

Harvard Business Review

JUNE 24, 2015

Positional advantage is sustainable in a classical environment: the environment is predictable and develops gradually without major disruptions. It is today the largest player in the CRO industry which it created and has been associated with the development or commercialization of the top fifty best-selling drugs currently on the market.

Strategy 8

Strategy Competitive Advantage Environment Execution 8